Fig. 2From: Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional responseOsteosarcoma patient with multiple recurrences whose tumor progressed on several lines of therapy, now treated successfully with matched targeted combination treatment approach. Therapy ongoing at 51 + months. A (PET scan) and B (CT scan). Osteosarcoma patient with multiple recurrences whose tumor progressed on several lines of therapy, now treated successfully with matched targeted combination treatment approach. Therapy ongoing at 51 + monthsBack to article page